Momentum Group (MTM) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
9 Jul, 2026Executive summary
Delivered normalized headline earnings of ZAR 3.437 billion for the six months ended 31 December 2024, up 44% year-on-year, with all business units contributing positively and strong segment performance.
Achieved the same level of earnings in six months as in the full prior financial year, even after adjusting for once-off market variances.
Declared an interim dividend of ZAR 0.85 per share, up 42%, and announced a further ZAR 1 billion share buyback.
Strong operational performance across all segments, with notable turnarounds in Momentum Insure and Metropolitan, and robust cash generation.
Impact strategy execution and digital transformation initiatives drove efficiency and profitability improvements.
Financial highlights
Normalized headline earnings rose 44% to ZAR 3.437 billion; normalized headline earnings per share increased 48% to 245 cents.
Interim dividend per share up 42% to 85 cents; dividend payout ratio at 35% of NHE.
Return on equity annualized at 24.6%, the highest in the industry.
Embedded value per share at ZAR 39.29, with share price trading at a discount to EV.
Value of new business up 40% to ZAR 279 million, with new business margin improved to 0.7%.
Outlook and guidance
Confident in achieving F2027 financial ambitions, targeting mid-teens group earnings growth, NHE of ZAR 7 billion, ROE of 20%, and VNB margin of 1–2%.
Focus remains on profitable growth, disciplined risk management, and further cost optimization.
Cautiously optimistic outlook, noting that favorable investment and underwriting conditions may not persist.
Anticipates benefits from lower repo rates and inflation, with potential economic uplift from reduced load shedding and improved logistics.
Remains focused on improving VNB and sales growth.
Latest events from Momentum Group
- Digital transformation and cost optimisation drive sustainable growth and capital efficiency.MTM
CMD 20258 Jul 2026 - Three-year plan targets ZAR 7bn earnings, 20% ROE, and advice-led, digital-driven growth.MTM
Investor Update8 Jul 2026 - Earnings rose to ZAR 1.76bn, but VNB margin fell to 0.7% amid lower annuity sales.MTM
Q1 20268 Jul 2026 - Earnings up 15% to ZAR 5.54bn, ROE at 23.3%, and Bonitas onboarding marks a major milestone.MTM
Q3 20263 Jul 2026 - Strong ROE, digital transformation, and disciplined execution drive ongoing momentum.MTM
CMD 202610 Jun 2026 - Earnings up 8%, dividend up 29%, solvency strong, and health admin expands with Bonitas.MTM
Q2 202631 Mar 2026 - Earnings up 27% to ZAR 4.4bn, record sales, digital growth, and ZAR 1bn buyback approved.MTM
Q4 20243 Feb 2026 - Strong new business growth, improved claims ratios, and robust solvency position.MTM
Q3 202431 Jan 2026 - Earnings and new business growth strong, with improved VNB and robust capital position.MTM
Q1 202513 Jan 2026